The discussion highlights the urgent need for AI solutions in addressing the growing diabetes crisis, with over 35 million people in the US alone affected. Major tech companies and startups are actively developing tools for diabetic retinopathy screening, recognizing the humanitarian impact and market potential. Collaboration among industry leaders is emphasized as a crucial strategy to tackle this enormous challenge effectively.
